Barclays Lowers Chemours (NYSE:CC) Price Target to $28.00
Chemours (NYSE:CC – Get Free Report) had its price target reduced by equities researchers at Barclays from $31.00 to $28.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s target price points to a potential upside of 15.99% […]